Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$560,644,681
+$13,510,547 QoQ
Shares Held
1,548,229
-0.4% QoQ
Ownership
0.286%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#40
of 3,131 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STIFEL FINANCIAL CORP holds $5,426,093,696 across 17 Drug Manufacturers - General names. AMGN ranks #5 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,454,737 | $1,131,369,551 | |
| 2 | MRK |
Merck & Co., Inc.
|
8,169,394 | $1,049,767,127 | |
| 3 | LLY |
ELI LILLY & Co
|
786,902 | $943,833,942 | |
| 4 | ABBV |
AbbVie Inc.
|
3,625,155 | $912,234,002 | |
| 5 | AMGN |
Amgen Inc
This page
|
1,548,229 | $560,644,681 | |
| 6 | PFE |
Pfizer Inc
|
9,980,325 | $240,326,222 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,152,519 | $145,609,245 | |
| 8 | AZN |
Astrazeneca PLC
|
670,847 | $127,206,004 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $560,644,681 | 1,548,229 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $547,134,134 | 1,555,021 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $521,852,913 | 1,594,369 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $434,710,754 | 1,540,435 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $423,017,386 | 1,515,051 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $452,032,877 | 1,450,916 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $365,533,001 | 1,402,444 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $453,916,558 | 1,408,760 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $456,680,352 | 1,461,611 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $407,469,225 | 1,433,136 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $391,183,288 | 1,358,181 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $364,138,083 | 1,354,882 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $292,178,540 | 1,316,001 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $310,086,920 | 1,282,676 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $267,718,667 | 1,019,337 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $224,673,307 | 996,776 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $233,316,425 | 958,966 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $226,141,839 | 935,166 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $201,241,286 | 894,525 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $181,456,368 | 853,310 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $207,678,654 | 852,015 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $205,436,939 | 825,678 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $180,244,631 | 783,945 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $191,574,622 | 753,756 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $168,338,703 | 713,723 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $135,775,374 | 669,735 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||